Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion type Assertion NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_head.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion evidence source_evidence_literature NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion SIO_000772 12822676 NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion wasDerivedFrom gad-20150221 NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.
- NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_assertion wasGeneratedBy ECO_0000203 NP77292.RAa4nvUZR8ntXmr6tnO1NqTKyNDkIRcCgW21KhH3yR26Y130_provenance.